Objective-Approximately 13% of aortic valves removed from patients with end-stage aortic valve disease contain heterotopic ossification (HO). Recently, we identified a novel population of circulating osteogenic precursor (COP) cells that are derived from bone marrow and have the capability to form bone. These cells are identified by coexpression of the osteogenic marker type 1 collagen or osteoclacin and the hematopoietic marker CD45. We tested the hypothesis that these cells may contribute to heart valve stenosis. Methods and Results-Quantification of CD45 ϩ osteoclacin ϩ COP cells by flow cytometry showed that they represent up to 1.1% of mononuclear cells. Clonally derived COP cells produce bone morphogenetic proteins 2 and 4 by immunohistochemical analysis. We reviewed 105 cases of end-stage aortic valvular disease and confirmed HO in 13 archived specimens. Using immunohistochemistry, we identified COP cells by coexpression of CD45 and type 1 collagen. There was a statistically significant association between the presence of COP cells and early HO lesions. COP cells were negligible in regions of unaffected valve leaflets (no HO) from the same individuals. Conclusion-This study provides the first evidence that osteogenic cells in the blood home to sites of vascular injury and are associated with HO formation in heart valves. (Arterioscler Thromb Vasc Biol. 2011;31:2965-2971.)
T he pathogenesis of aortic valve stenosis involves active processes of inflammation, changes in lipid metabolism, dystrophic calcification, and bone formation. 1 The aortic valve undergoes continuous repair to remain pliable, and aberrant tissue remodeling with age results in the accumulation of calcium (hydroxyapatite mineral), sclerotic tissue, and ultimately heterotopic ossification (HO) through an endochondral mechanism. 2 Mature lamellar bone formation, bone remodeling, and even microfracture repair occur in the end-stage stenotic valve. 2 The cells responsible for ectopic bone formation in end-stage disease are unknown. 3 
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Recently, we described circulating osteogenic precursor (COP) cells as a bone marrow-derived type 1 collagen ϩ /CD45 ϩ subpopulation of mononuclear adherent cells that are present in early preosseous (fibroproliferative) lesions of HO. 4 These cells were able to produce extraskeletal ossification in a murine in vivo implantation assay. 4 That circulating, hematopoietic-derived cells with osteogenic potential can seed inflammatory sites suggested the possibility of their involvement in end-stage aortic valve disease. 5 Approximately 13% of heart valves removed from patients with end-stage aortic valve disease contain HO. 2 Here, we tested the hypothesis that COP cells may contribute to heart valve stenosis and examined their presence in surgically removed aortic heart valves containing HO. By immunohistochemistry, we identified COP cells by coexpression of CD45 and type 1 collagen. COP cells were found in early lesions of HO in all of the samples examined but were negligible or absent in regions of unaffected valve leaflets (no HO) from the same individuals. This study provides evidence that osteogenic cells in the blood home to sites of vascular injury and are associated with HO formation in affected heart valves.
Methods

Patients
Archived tissue blocks and blood samples were obtained in accordance with institutional guidelines and with institutional review board approval at the University of Pennsylvania. Heart valves had been excised (because of valvular stenosis or regurgitation) during cardiac valve replacement surgery between 1994 and 1998 at the University of Pennsylvania Health System. 2 One hundred five cases of confirmed aortic stenosis were reviewed for pathological evaluation of cardiac valves and patient demographic information. Blood samples from a patient with aortic stenosis, as well as an age-and sex-matched control, were also obtained for analysis by flow cytometry.
Histological Evaluation of Heart Valves
Formalin-fixed tissue specimens undergoing limited demineralization for 2 days with 10% formic acid treatment were consecutively sectioned at a depth of 5 m for routine histological analysis and confirmation of heterotopic bone. Only those valves showing HO were used for further study. Hematoxylin/eosin, alizarin red, and picosirius red staining was performed per standard methods. 6 Masson trichrome straining was performed according to the manufacturer's instructions (American Mastertech, Lodi, CA). Movat staining was performed by the Molecular Cardiology Research Center at the University of Pennsylvania. To illustrate regions of interest (ROIs), low-power images of heart valves (ϫ20) were taken and compiled, and a mask was created by selecting eosin-stained bone tissue and converting it to an all-black color using Adobe Photoshop CS2. ROIs within each heart valve were defined by arbitrary division of each leaflet into quarter sections for evaluation of the presence of ectopic ossification.
Immunofluorescence Studies
Heat-induced epitope retrieval at pH 6.0 in 10 mmol/L sodium citrate buffer was performed on all sections. After being heated to 95°C for 20 minutes, sections were cooled to room temperature in the buffer. Sections were blocked using 20% serum derived from the same species in which the secondary antibodies were produced. Primary antibodies against CD45 (Santa Cruz Biotechnology) and type 1 collagen (Fitzgerald Industries) or osteoclacin (OCN) (Santa Cruz Biotechnology) were diluted to 1:100 and incubated with sections for 18 hours in a dark humidity chamber at 4°C. For negative controls, sections were incubated with normal serum from the same species in which the primary antibodies were produced and at the same concentration as the primary antibodies. Following primary antibody incubation, sections were washed twice for 5 minutes in 0.2% Tween-20. Secondary antibodies against mouse and rabbit IgGs, tagged with Alexa 555 and Alexa 647 fluorescent labels, respectively, were incubated at a concentration of 1:1000 in a dark humidity chamber for 60 minutes. After washing twice for 5 minutes with 0.2% Tween-20, 4Ј,6-diamidino-2-phenylindole was incubated with sections for 5 minutes, followed by a final wash in 0.2% Tween-20 for 5 minutes.
Cultured COP cells were grown on fibronectin-coated coverslips, grown to approximately 60% confluence in ␣-minimal essential medium plus 10% fetal bovine serum, and fixed with 4% paraformaldehyde for 10 minutes at room temperature. After 2 washes with PBS, the cells were permeabilized with 0.1% Triton X-100 in PBS for 10 minutes at room temperature. After blocking with human serum (type AB, Fisher BP2525) for 30 minutes at 4°C, primary antibodies against bone morphogenetic protein (BMP) 2 (Abcam 39973) or BMP4 (Abcam 14933) were diluted to a concentration of 3 g/mL in 0.1% Triton X-100/PBS and incubated with the cells overnight at 4°C in the dark. After rinsing with high-salt solution (0.1 ϫ PBS, 0.4 mol/L NaCl, 1:2000 Tween 20) and PBS, secondary antibodies tagged with Alexa 647 fluorescent label were incubated with the cells at 2 mg/mL in 0.1% Triton X-100/PBS for 1 hour at 4°C in the dark. After undergoing high-salt and PBS washes as above, cells were then incubated with 4Ј,6-diamidino-2-phenylindole for 5 minutes. The cells were washed a final time with PBS. Negative controls were treated as described above.
Sections were viewed with a Nikon Eclipse 90i fluorescent microscope attached to a Photometrics Cool Snap HQ2 camera using NIS-elements Ar version 3.2. Emission times were standardized to the negative control slides. Automated z-stack images were taken and deconvolved to confirm colocalization.
Quantitation of COP Cells in Tissue Specimens
Two hundred cells (4Ј,6-diamidino-2-phenylindole positive) were scored in areas of fibroproliferative and neovascular tissue for Col 1 ϩ CD45 ϩ cells. Cells were scored in ROIs containing affected (HO present) or unaffected areas. Unaffected ROIs from the aortic valve of the same individual served as negative controls. COP cells were scored within ROIs in randomly selected high-power fields (ϫ400).
Flow Cytometry
A modified standard staining protocol for surface molecules was used. 7 A Becton Dickinson FACSCanto A running DiVa software was used to analyze 1 000 000 total events for each experimental sample and 250 000 events for fluorescence minus 1 controls. 8 Complete details for flow cytometry are described in the supplemental material, available online at http://atvb.ahajournals.org.
Statistical Analysis
The t test (Student t test; 2-sided and paired) was used to determine whether the mean value for the number of COP cells (continuous variable) in the affected ROIs differed significantly from those in the unaffected (control) ROIs, or in affected ROIs in men versus women. Statistical significance was set to Pϭ0.05. All statistics were performed using GraphPad software.
Results
We previously described a population of bone marrowderived COP cells capable of forming bone in vivo. 4 These cells are identified by the coexpression of the osteogenic marker type 1 collagen or OCN and the hematopoietic marker CD45. Quantification of CD45 ϩ OCN ϩ COP cells from peripheral blood by flow cytometry showed that they represented up to 1.1% of mononuclear cells ( Figure 1A ). Of the CD45 ϩ OCN ϩ COP cells derived from the patient with aortic stenosis, 89.5% were CXCR4 positive (73.2% of CD45 ϩ OCN ϩ COP cells derived from the age-matched control were CXCR4 positive). CD45 ϩ OCN ϩ COP cells from strains propagated in vitro were almost 88% positive for type 1 collagen ( Figure 1B ). We previously demonstrated that COP cell strains derived from peripheral blood respond to BMP2 by undergoing matrix mineralization. 4 Adherent, clonally derived COP cells also produced BMP2 and BMP4 (Supplemental Figure I ). Of the 105 cases of aortic heart valve replacement surgery reviewed, 13 had histologically confirmed heterotopic endochondral ossification in the setting of dystrophic calcification, and these ossified valves were further examined for histological stages. Ossification of aortic heart valves proceeds through several stages, including infiltration of inflammatory cells, fibroproliferation, neovascularity, and endochondral bone formation ( Figure 2 ). Areas of mature bone were present, as evidenced by the characteristic architecture, including osteocytes and bonelining cells (Figure 2E, 2J, 2O, 2T, and 2Y ). Within the limits of this study, there was no consistent involvement of valve/leaflet layers with HO, and endochondral ossification was often found extending to variable depths. COP cells were identified as CD45 ϩ Col 1 ϩ cells and were found in early lesions of fibroproliferation and neovascularization (Figures 3 and 4 ). Approximately 70% of COP cells were present in fibroproliferative tissue and Ϸ30% in neovascular tissue. CD45 ϩ cells were found in both affected and unaffected regions.
As illustrated in Supplemental Figure II , aortic valve specimens were arbitrarily divided into ROIs representing Table) . COP cells were found in fibroproliferative and neovascular areas only in sites of calcification associated with HO.
The abundance of COP cells associated with HO varied from as little as 3.5% to as much as 20.5% (Table) . COP cells were present in affected regions of stenotic aortic heart valves irrespective of valve etiology (Table) . There was no statisti-cally significant difference between the number of COP cells in affected ROIs from valves excised from men versus women (Pϭ0.3769).
Discussion
The presence of heterotopic bone in advanced vascular lesions has been described for end-stage aortic valve disease, 2 carotid plaques, 9 and peripheral artery disease. 10 In other cases, surrogate markers for bone formation, such as osteopontin, osteonectin, matrix gla protein, and BMPs, have been associated with vascular disease and vascular aging. [11] [12] [13] [14] [15] Markers of bone formation have also been associated with vascular disease in animal models of aortic and myocardial calcification. 12, 16 Human studies, as well as animal and cell culture models, have suggested that osteoblast-like cells are present in aortic heart valves and have been described as myofibroblasts. 2, 3, 17, 18 It is widely held that cells with an osteoblastlike phenotype are present in calcified aortic valves and that they can differentiate into bone-forming cells. 19 However, the possibility also exists that progenitor cells home to sites of vascular injury and inflammation and, once resident, are responsible for subsequent ossification.
Here we describe the presence of COP cells within affected heart valve leaflets showing heterotopic bone. We have recently characterized human COP cells as bone marrowderived type 1 collagen ϩ /CD45 ϩ cells that form bone in an in vivo allotransplantation model and are present in preosseous fibroproliferative lesions of ectopic ossification in skeletal muscle. 4 We also showed that COP cells are similar if not identical to fibrocytes, circulating cells that mediate disparate processes such as wound repair and fibrosis. 4 Schmidt et al 20 have identified circulating fibrocytes as precursors of bronchial myofibroblasts in asthma, and so it is possible that the previously described aortic valve myofibroblasts are derived from or in fact are COP cells.
Aortic valve ossification may be precipitated by endothelial injury, causing the presumptive release of inflammatory cytokines and migratory factors. Vascular injury as a trigger is supported by the presence of a damaged endothelial cell layer in calcified aortic valves. 21 Inflammation mediated by endothelial dysfunction and cytokine production (particularly transforming growth factor-␤) may play a causal role in early aortic valve disease. 17, [22] [23] [24] Elevated levels of adhesion molecules, T lymphocytes, and monocytes are present in calcified valves, [25] [26] [27] [28] [29] [30] suggesting that an inflammatory infiltrate is necessary for lesion formation and progression. Interestingly, BMP4 is chemotactic for human monocytes and stimulates transforming growth factor-␤1 mRNA expression. 31 Further support for the involvement of an inflammatory response in vascular calcification and ossification is provided by animal studies where macrophage abundance is associated with early-stage atherosclerosis 32, 33 and in human studies where myeloid calcifying cells may play a role in atherosclerotic lesions in patients with type 2 diabetes. 34 Animal models of heterotopic bone formation demonstrate that inflammatory signals are necessary to trigger distant ossification in a BMP conducive environment. [35] [36] [37] In one of these models, cells of the monocyte lineage were required for initiating extraskeletal bone following injury. 35 COP cells, as well as monocyte-derived mesenchymal progenitors, are derived from CD14 ϩ precursors 38 and can be induced to differentiate into osteoblast-like cells. 39 Our current findings in aortic heart valves are thus consistent with the role of monocyte-derived COP cells as mediators of ossification in late-stage vascular lesions.
COP cells express a variety of osteogenic markers, including type 1 collagen, alkaline phosphatase, osteonectin, osteopontin, and osteocalcin, and hematopoietic markers, such as CD13 (pan-myeloid antigen), CD45 (leukocyte common antigen), and CD34 (hematopoietic stem cell). 4 Type 1 collagen expression in the setting of a hematopoietic background identifies circulating fibrocytes and is the basis for their similarity to COP cells. Circulating mononuclear cells, defined on the basis of these makers, have been associated with vascular disease. For example, monocytes contribute to atherosclerotic caps by transformation into fibrocytes in human carotid endarterectomy specimens. 40 Similarly, osteocalcin-positive mononuclear cells were associated with the severity of aortic calcification in osteoprotegerin-deficient mice that develop medial aortic calcification, as well as in patients with peripheral artery disease. 16 In senile apolipoprotein E-deficient mice that develop degenerative aortic valvular sclerosis resembling human aortic stenosis, transplanted bone marrow-derived cells that express osteoblast markers were found near sites of ectopic calcification. 41 These studies and results from this investigation support the association of COP cells with HO in end-stage aortic valvular disease.
Endothelial dysfunction mediated by reactive oxygen species, vascular injury, hypoxia, and inflammation occurs in the setting of hypercholesterolemia and other cardiovascular risk factors and is thought to predispose to aortic valve calcification ( Figure 5 ). 1, 19 BMPs and perhaps stromal cell-derived factor-1 (SDF-1) contribute to endothelial dysfunction, and dysfunctional endothelium may also promote upregulation of BMPs and SDF-1 ( Figure 5 ). [42] [43] [44] [45] [46] [47] Given their known roles in tissue injury and chemotaxis, SDF-1 and BMPs are obvious candidates for signaling in the inflammatory soft tissue microenvironment. 31,48 -50 These factors may recruit COP cells to sites of vascular lesion formation, but it is still unclear when these circulating cells are committed to their osteoblast-like fate ( Figure 5 ). It is also unclear whether patients with vascular disease, including those with aortic valve stenosis, have elevated levels of COP cells in peripheral blood, and if so, whether these levels are continuously elevated or only transiently high depending on the stage of the lesion. Although a direct relationship between COP cell levels in peripheral blood and their abundance in preosseous valve lesions is tempting to postulate, this association remains to be established. As defined in this study, CD45 ϩ OCN ϩ COP cells represent up to 1.1% of circulating mononuclear cells by flow cytometry and are likely to vary by age, local and systemic inflammatory conditions, and yet unidentified humoral factors. Additional studies in animal models of aortic calcification and ossification are needed to control for known variables and to correlate levels of circulating progenitor cells with their presence in early vascular lesions.
Table. Circulating Osteogenic Precursor (COP) Cells Are Associated With Areas of Heterotopic Ossification in End-Stage Aortic Valves
COP cells may home to sites of injury, perhaps through CXCR4 expression in a manner analogous to fibrocyte involvement in lesions of pulmonary fibrosis. 49 In a mouse model of BMP2-induced heterotopic ossification, osteoblast progenitor cells expressed CXCR4 and migrated to regions of extraskeletal bone formation by SDF-1 chemoattraction. 51, 52 There is growing evidence that in an inflammatory milieu, SDF-1 and BMPs may serve as important chemoattractant molecules and mediate homing of CXCR4-positive stem cells to sites of injury or hypoxia. 5,48 -50 In addition to serving as potential chemoattractant molecules, BMPs may also mediate the ossification process in end-stage aortic valvular disease. 1 In the current study, we have shown that COP cells express BMP2 and BMP4; thus, the presence of cells that both produce and respond to BMPs in early calcific lesions may be a prerequisite for subsequent endochondral bone formation. 4 BMP2 acts synergistically with ␤-catenin to promote osteoblast differentiation, and BMP2 stimulates low-density lipoprotein receptor-related protein-5 expression and inhibits ␤-catenin degradation. 53 A report by Caira et al suggests that there is an association between low-density lipoprotein receptor-related protein-5mediated bone formation and aortic valvular heart disease. 54 Taken together, these findings suggest that BMPs may regulate ossification of aortic heart valves, in part through modulation of ␤-catenin signaling.
Progression to end-stage aortic valve disease characterized by dystrophic calcification, stenosis, and endochondral bone formation is a dynamic rather than a passive process. Although we cannot completely exclude the possibility that osteoblast-like cells resident in local tissue contribute to ectopic ossification in heart valves, our data strongly support the emerging paradigm that circulating osteogenic cells home to sites of valvular injury and are intimately associated with bone formation. 
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